<DOC>
	<DOCNO>NCT02940535</DOCNO>
	<brief_summary>The management poor responder patient difficult . Currently , standard treatment poor responder patient . The study design test modify GnRHa protocol poor ovarian response , low dose GnRHa early luteal phase regulation , compare GnRHa ultra-short protocol . This randomize controlled trial .</brief_summary>
	<brief_title>Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol Poor Ovarian Response</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>At least two follow three feature must present : . Advanced maternal age ( ≥40 year ) risk factor POR ( poor ovarian response ) ; ii . A previous POR ( ≤3 oocytes conventional stimulation protocol ) ; iii . An abnormal ovarian reserve test ( i.e . AFC &lt; 7 follicle AMH &lt; 1.1 ng/ml ) . Contraindications IVF/ICSI Contraindications pregnancy Primary ovarian insufficiency AFC &lt; 3 PGD/PGS</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>